CH de Chateauroux
About CH de Chateauroux
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University Hospital, Angers
3
ARCAGY/ GINECO GROUP
1
Biotronik France
1
Centre Hospitalier Departemental Vendee
1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
1
GERCOR - Multidisciplinary Oncology Cooperative Group
1
KU Leuven
1
The Medicines Company
1
University Hospital, Bordeaux
1
University Hospital, Limoges
1
University Hospital, Toulouse
1
Clinical Trials at CH de Chateauroux
During the past decade, CH de Chateauroux conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Strategies for Suspected Pulmonary Embolism in Emergency Departments
2005-06-01
2006-09-01
Completed
1,331
Use or Non-use of Epoetin Beta in Patients Infected by Chronic Hepatitis C
2005-12-01
2009-06-01
Completed
229
European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
2010-03-01
2014-08-01
Completed
2,198
Procedures of Locoregional Analgesia and Quality of Life in Palliative Care Units
2010-04-01
2015-10-01
Suspended
38
Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)
2010-07-01
2013-11-01
Completed
602
Prevention of Venous Thromboembolism Disease in Emergency Departments
2009-09-01
2013-06-01
Completed
20,000
Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver Disease
2010-11-23
2020-12-12
Completed
527
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CH de Chateauroux" #1 sponsor was "University Hospital, Angers" with 3 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials
sponsored, "Biotronik France" with 1 trials sponsored, "Centre Hospitalier Departemental Vendee" with 1 trials sponsored and "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Chateauroux"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Fund for Clinical Cardiovascular Research at LRD" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at CH de Chateauroux
According to Clinical.Site data, the most researched conditions in "CH de Chateauroux" are
"Acute Coronary Syndrome" (2 trials), "Chronic Hepatitis C" (2 trials), "Quality of Health Care" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "CH de Chateauroux" in a lesser frequency.
Clinical Trials Intervention Types at CH de Chateauroux
Most popular intervention types in "CH de Chateauroux" are "Drug" (5 trials), "Other" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab)" (1 trials), "Bivalirudin" (1 trials), "Clopidogrel" (1 trials), "Computer-Assisted diagnostic Decision Support" (1 trials) and "Coronary angiography" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CH de Chateauroux
The vast majority of trials in "CH de Chateauroux" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at CH de Chateauroux
Currently, there are NaN active trials in "CH de Chateauroux".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in CH de Chateauroux,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in CH de Chateauroux, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 3 trials that are defined as “Not Applicable".